Annual CAPEX
$255.00 K
+$45.00 K+21.43%
31 December 2021
Summary:
Concert Pharmaceuticals annual capital expenditures is currently $255.00 thousand, with the most recent change of +$45.00 thousand (+21.43%) on 31 December 2021. During the last 3 years, it has risen by +$45.00 thousand (+21.43%).CNCE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$96.00 K
+$19.00 K+24.68%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly capital expenditures is currently $96.00 thousand, with the most recent change of +$19.00 thousand (+24.68%) on 30 September 2022.CNCE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$281.00 K
-$3000.00-1.06%
30 September 2022
Summary:
Concert Pharmaceuticals TTM capital expenditures is currently $281.00 thousand, with the most recent change of -$3000.00 (-1.06%) on 30 September 2022.CNCE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +21.4% | -3.0% | +6.4% |
| 5 y5 years | -91.1% | +100.0% | -71.4% |
CNCE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -91.1% | -92.0% | -90.2% |
Concert Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $96.00 K(+24.7%) | $281.00 K(-1.1%) |
| June 2022 | - | $77.00 K(-16.3%) | $284.00 K(+11.4%) |
| Mar 2022 | - | $92.00 K(+475.0%) | $255.00 K(0.0%) |
| Dec 2021 | $255.00 K(+21.4%) | $16.00 K(-83.8%) | $255.00 K(-3.4%) |
| Sept 2021 | - | $99.00 K(+106.3%) | $264.00 K(+17.9%) |
| June 2021 | - | $48.00 K(-47.8%) | $224.00 K(+17.9%) |
| Mar 2021 | - | $92.00 K(+268.0%) | $190.00 K(-9.5%) |
| Dec 2020 | $210.00 K(-69.3%) | $25.00 K(-57.6%) | $210.00 K(-40.0%) |
| Sept 2020 | - | $59.00 K(+321.4%) | $350.00 K(+3.2%) |
| June 2020 | - | $14.00 K(-87.5%) | $339.00 K(-29.7%) |
| Mar 2020 | - | $112.00 K(-32.1%) | $482.00 K(-29.6%) |
| Dec 2019 | $685.00 K(-76.1%) | $165.00 K(+243.8%) | $685.00 K(-30.4%) |
| Sept 2019 | - | $48.00 K(-69.4%) | $984.00 K(-45.9%) |
| June 2019 | - | $157.00 K(-50.2%) | $1.82 M(-36.3%) |
| Mar 2019 | - | $315.00 K(-32.1%) | $2.86 M(-0.3%) |
| Dec 2018 | $2.87 M(+203.0%) | $464.00 K(-47.5%) | $2.87 M(+6.3%) |
| Sept 2018 | - | $884.00 K(-26.1%) | $2.70 M(+20.5%) |
| June 2018 | - | $1.20 M(+268.0%) | $2.24 M(+99.6%) |
| Mar 2018 | - | $325.00 K(+10.5%) | $1.12 M(+18.5%) |
| Dec 2017 | $947.00 K | $294.00 K(-30.7%) | $947.00 K(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $424.00 K(+436.7%) | $1.13 M(+46.9%) |
| June 2017 | - | $79.00 K(-47.3%) | $768.00 K(-7.2%) |
| Mar 2017 | - | $150.00 K(-68.4%) | $828.00 K(+7.5%) |
| Dec 2016 | $770.00 K(-11.3%) | $475.00 K(+642.2%) | $770.00 K(+76.6%) |
| Sept 2016 | - | $64.00 K(-54.0%) | $436.00 K(-35.8%) |
| June 2016 | - | $139.00 K(+51.1%) | $679.00 K(-16.2%) |
| Mar 2016 | - | $92.00 K(-34.8%) | $810.00 K(-6.7%) |
| Dec 2015 | $868.00 K(+8.0%) | $141.00 K(-54.1%) | $868.00 K(-32.6%) |
| Sept 2015 | - | $307.00 K(+13.7%) | $1.29 M(+24.2%) |
| June 2015 | - | $270.00 K(+80.0%) | $1.04 M(+21.3%) |
| Mar 2015 | - | $150.00 K(-73.2%) | $854.00 K(+6.2%) |
| Dec 2014 | $804.00 K(+121.5%) | $560.00 K(+900.0%) | $804.00 K(+73.3%) |
| Sept 2014 | - | $56.00 K(-36.4%) | $464.00 K(+4.5%) |
| June 2014 | - | $88.00 K(-12.0%) | $444.00 K(+14.7%) |
| Mar 2014 | - | $100.00 K(-54.5%) | $387.00 K(+6.6%) |
| Dec 2013 | $363.00 K(-22.4%) | $220.00 K(+511.1%) | $363.00 K(+153.8%) |
| Sept 2013 | - | $36.00 K(+16.1%) | $143.00 K(+33.6%) |
| June 2013 | - | $31.00 K(-59.2%) | $107.00 K(+40.8%) |
| Mar 2013 | - | $76.00 K | $76.00 K |
| Dec 2012 | $468.00 K(+61.4%) | - | - |
| Dec 2011 | $290.00 K | - | - |
FAQ
- What is Concert Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual capital expenditures?
The current annual CAPEX of CNCE is $255.00 K
What is the all time high annual CAPEX for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual capital expenditures is $2.87 M
What is Concert Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of CNCE is $96.00 K
What is the all time high quarterly CAPEX for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly capital expenditures is $1.20 M
What is Concert Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of CNCE is $281.00 K
What is the all time high TTM CAPEX for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high TTM capital expenditures is $2.87 M